Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Statistics

Total Valuation

ASX:EYE has a market cap or net worth of AUD 36.93 million. The enterprise value is 38.05 million.

Market Cap	36.93M
Enterprise Value	38.05M

Important Dates

The next estimated earnings date is Monday, May 26, 2025.

Earnings Date	May 26, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:EYE has 284.08 million shares outstanding. The number of shares has increased by 25.32% in one year.

Current Share Class	n/a
Shares Outstanding	284.08M
Shares Change (YoY)	+25.32%
Shares Change (QoQ)	+5.48%
Owned by Insiders (%)	5.10%
Owned by Institutions (%)	21.38%
Float	240.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.41
PB Ratio	2.13
P/TBV Ratio	3.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.45
EV / Sales	1.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.16

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.19.

Current Ratio	1.84
Quick Ratio	0.98
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-0.46
Interest Coverage	-86.04

Financial Efficiency

Return on equity (ROE) is -49.77% and return on invested capital (ROIC) is -27.86%.

Return on Equity (ROE)	-49.77%
Return on Assets (ROA)	-21.93%
Return on Invested Capital (ROIC)	-27.86%
Return on Capital Employed (ROCE)	-43.01%
Revenue Per Employee	86,748
Profits Per Employee	-28,435
Employee Count	301
Asset Turnover	1.05
Inventory Turnover	1.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.62, so ASX:EYE's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-50.00%
50-Day Moving Average	0.10
200-Day Moving Average	0.16
Relative Strength Index (RSI)	73.92
Average Volume (20 Days)	381,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EYE had revenue of AUD 26.11 million and -8.56 million in losses. Loss per share was -0.04.

Revenue	26.11M
Gross Profit	21.81M
Operating Income	-8.69M
Pretax Income	-8.56M
Net Income	-8.56M
EBITDA	-5.73M
EBIT	-8.69M
Loss Per Share	-0.04

Balance Sheet

The company has 2.26 million in cash and 3.38 million in debt, giving a net cash position of -1.12 million or -0.00 per share.

Cash & Cash Equivalents	2.26M
Total Debt	3.38M
Net Cash	-1.12M
Net Cash Per Share	-0.00
Equity (Book Value)	17.38M
Book Value Per Share	0.08
Working Capital	4.56M

Cash Flow

In the last 12 months, operating cash flow was -7.27 million and capital expenditures -110,000, giving a free cash flow of -7.38 million.

Operating Cash Flow	-7.27M
Capital Expenditures	-110,000
Free Cash Flow	-7.38M
FCF Per Share	-0.03

Margins

Gross margin is 83.53%, with operating and profit margins of -33.28% and -32.78%.

Gross Margin	83.53%
Operating Margin	-33.28%
Pretax Margin	-32.78%
Profit Margin	-32.78%
EBITDA Margin	-21.93%
EBIT Margin	-33.28%
FCF Margin	n/a

Dividends & Yields

ASX:EYE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.32%
Shareholder Yield	-25.32%
Earnings Yield	-23.18%
FCF Yield	-19.97%

Stock Splits

The last stock split was on July 10, 2001. It was a reverse split with a ratio of 0.2.

Last Split Date	Jul 10, 2001
Split Type	Reverse
Split Ratio	0.2

Scores

ASX:EYE has an Altman Z-Score of 1.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.64
Piotroski F-Score	n/a